Skip to content

Student page · Grades 9–12

After the listing: from final prospectus to first 10-Q

Once a company's shares start trading, it has to report its results to the public every quarter. In this lesson you will follow one company from its final prospectus to its first quarterly report.

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

What to do

  1. Read the CoreWeave cards below with a partner.
  2. In Part C of your worksheet, put its filings in order and compare each quarter with a year earlier.
  3. In Part D, work out which quarter each 2026 listing's first 10-Q will cover.
  4. The exit ticket is on page 2 of your worksheet.

Warm-up

A company has just started trading on a stock exchange. List two things you would expect it to tell the public every three months.

CoreWeave's first year as a public company

CoreWeave rents out cloud computing on NVIDIA chips. Source: its filings, as shown on its Cityfort stock page. Checked Nov 15, 2026.

  • Final prospectus (424B4): dated Mar 27, 2025, filed Mar 31, 2025. Shares began trading on Nasdaq on Mar 28, 2025.
  • First earnings release (Form 8-K): May 14, 2025. First 10-Q, for the quarter ended Mar 31, 2025: filed May 15, 2025.
  • Q1 FY2025 (quarter ended Mar 31, 2025): revenue $982 million; net loss $314.6 million. Same quarter a year earlier: revenue $188.7 million; net loss $129.2 million.
  • Q2 FY2025 (quarter ended Jun 30, 2025; 10-Q filed Aug 13, 2025): revenue $1,212.8 million; net loss $290 million. Same quarter a year earlier: revenue $395.4 million; net loss $323 million.

Three 2026 listings

Source: each company's final prospectus, as shown on its Cityfort stock page.

  • Accelevation (designs and installs power and equipment systems for data centers): 424B4 dated Sep 29, 2026; trading on Nasdaq began Sep 30, 2026; its financial statements run to Jun 30, 2026.
  • City Therapeutics (develops gene-silencing medicines): 424B4 dated Oct 15, 2026; trading on Nasdaq began Oct 16, 2026; its financial statements run to Jun 30, 2026.
  • Lycia Therapeutics (tests medicines meant to remove disease-causing proteins): 424B4 dated Oct 22, 2026; trading on Nasdaq began Oct 23, 2026; its financial statements run to Jun 30, 2026.

Read the filings yourself

Questions

  1. What is a 10-Q, and how often is it filed?
  2. Why compare a quarter with the same quarter a year earlier?
  3. Where in a first 10-Q does a company report how it used its IPO money?

Word bank

424B4:
The final prospectus, filed after the shares are priced.
Earnings release:
A press release with quarterly results, filed with a Form 8-K.
10-Q:
The quarterly report a public company files for each of its first three quarters.
Year-over-year:
Compared with the same period a year earlier.
Net loss:
What is left when costs are larger than revenue: profit below zero.

Sentence starters

  • In Q____ FY____, ____'s revenue was $____, against $____ in the same quarter a year earlier.
  • ____'s first 10-Q was filed on ____ and covered the quarter ended ____.
  • Revenue changed by ____% from Q____ FY____ to Q____ FY____.

Data from CoreWeave's IPO Form 424B4 final prospectus, filed Mar 31, 2025; CoreWeave's Q1 FY2025 earnings release (Form 8-K), filed May 14, 2025; CoreWeave's Q1 FY2025 Form 10-Q, filed May 15, 2025; CoreWeave's Q2 FY2025 Form 10-Q, filed Aug 13, 2025; Accelevation's IPO Form 424B4 final prospectus, filed Oct 1, 2026; City Therapeutics's IPO Form 424B4 final prospectus, filed Oct 16, 2026; and Lycia Therapeutics's IPO Form 424B4 final prospectus, filed Oct 23, 2026. Checked Nov 15, 2026.